Toll-like receptor 4: A target for chemoprevention of hepatocellular carcinoma in obesity and steatohepatitis

Jennifer Nguyen, Jingjing Jiao, Kristin Smoot, Gordon P. Watt, Chen Zhao, Xingzhi Song, Heather Stevenson-Lerner, Joseph B. McCormick, Susan P. Fisher-Hoch, Jianhua Zhang, P. Andrew Futreal, Laura Beretta

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The incidence of hepatocellular carcinoma (HCC) associated with non-alcoholic fatty liver disease (NAFLD) is rapidly increasing. We aimed to elucidate the genetic basis of NAFLD-associated HCC and identify candidate targets for chemoprevention. Twenty HCC tumors, distant liver and matched tails from mice with hepatocytedeletion of Pten (HepPten-) were subjected to whole-exome sequencing. A total of 162 genes with somatic non-synonymous single nucleotide variants or exonic small insertions and deletions in tumors were identified. Ingenuity Pathway Analysis of these 162 genes, further identified Toll-like receptor (TLR) 4, a key mediator of proinflammatory responses, and resatorvid, a TLR4 inhibitor, as the main causal networks of this dataset. Resatorvid treatment strongly prevented HCC development in these mice (p < 0.001). Remarkably, HCC patients with high tumoral TLR4 mRNA expression were more likely to be diagnosed with NAFLD and obese. TLR4 mRNA expression positively correlated with IL-6 and IL-10 mRNA expression in HCC tumors and the correlation was stronger in obese HCC patients. We have identified tumor mutation signatures and associated causal networks in NAFLD-associated HCC in HepPten- mice and further demonstrated the important role of TLR4 in promoting HCC development. This study also identified IL-6 and IL-10 as markers of TLR4 activation in HCC and subjects with NAFLD and obesity as the target population who would benefit from TLR4 inhibition treatment for HCC chemoprevention.

Original languageEnglish (US)
Pages (from-to)29495-29507
Number of pages13
JournalOncotarget
Volume9
Issue number50
DOIs
StatePublished - Jun 29 2018

Fingerprint

Toll-Like Receptor 4
Chemoprevention
Fatty Liver
Hepatocellular Carcinoma
Obesity
Interleukin-10
Messenger RNA
Interleukin-6
Neoplasms
Exome
Health Services Needs and Demand
Genes
Tail
Nucleotides
Non-alcoholic Fatty Liver Disease

Keywords

  • Chemoprevention
  • Hepatocellular carcinoma
  • Mouse model
  • NAFLD
  • Toll-like receptor 4

ASJC Scopus subject areas

  • Oncology

Cite this

Nguyen, J., Jiao, J., Smoot, K., Watt, G. P., Zhao, C., Song, X., ... Beretta, L. (2018). Toll-like receptor 4: A target for chemoprevention of hepatocellular carcinoma in obesity and steatohepatitis. Oncotarget, 9(50), 29495-29507. https://doi.org/10.18632/oncotarget.25685

Toll-like receptor 4 : A target for chemoprevention of hepatocellular carcinoma in obesity and steatohepatitis. / Nguyen, Jennifer; Jiao, Jingjing; Smoot, Kristin; Watt, Gordon P.; Zhao, Chen; Song, Xingzhi; Stevenson-Lerner, Heather; McCormick, Joseph B.; Fisher-Hoch, Susan P.; Zhang, Jianhua; Andrew Futreal, P.; Beretta, Laura.

In: Oncotarget, Vol. 9, No. 50, 29.06.2018, p. 29495-29507.

Research output: Contribution to journalArticle

Nguyen, J, Jiao, J, Smoot, K, Watt, GP, Zhao, C, Song, X, Stevenson-Lerner, H, McCormick, JB, Fisher-Hoch, SP, Zhang, J, Andrew Futreal, P & Beretta, L 2018, 'Toll-like receptor 4: A target for chemoprevention of hepatocellular carcinoma in obesity and steatohepatitis', Oncotarget, vol. 9, no. 50, pp. 29495-29507. https://doi.org/10.18632/oncotarget.25685
Nguyen, Jennifer ; Jiao, Jingjing ; Smoot, Kristin ; Watt, Gordon P. ; Zhao, Chen ; Song, Xingzhi ; Stevenson-Lerner, Heather ; McCormick, Joseph B. ; Fisher-Hoch, Susan P. ; Zhang, Jianhua ; Andrew Futreal, P. ; Beretta, Laura. / Toll-like receptor 4 : A target for chemoprevention of hepatocellular carcinoma in obesity and steatohepatitis. In: Oncotarget. 2018 ; Vol. 9, No. 50. pp. 29495-29507.
@article{a5a78b9b69d04c278290df263e97d44a,
title = "Toll-like receptor 4: A target for chemoprevention of hepatocellular carcinoma in obesity and steatohepatitis",
abstract = "The incidence of hepatocellular carcinoma (HCC) associated with non-alcoholic fatty liver disease (NAFLD) is rapidly increasing. We aimed to elucidate the genetic basis of NAFLD-associated HCC and identify candidate targets for chemoprevention. Twenty HCC tumors, distant liver and matched tails from mice with hepatocytedeletion of Pten (HepPten-) were subjected to whole-exome sequencing. A total of 162 genes with somatic non-synonymous single nucleotide variants or exonic small insertions and deletions in tumors were identified. Ingenuity Pathway Analysis of these 162 genes, further identified Toll-like receptor (TLR) 4, a key mediator of proinflammatory responses, and resatorvid, a TLR4 inhibitor, as the main causal networks of this dataset. Resatorvid treatment strongly prevented HCC development in these mice (p < 0.001). Remarkably, HCC patients with high tumoral TLR4 mRNA expression were more likely to be diagnosed with NAFLD and obese. TLR4 mRNA expression positively correlated with IL-6 and IL-10 mRNA expression in HCC tumors and the correlation was stronger in obese HCC patients. We have identified tumor mutation signatures and associated causal networks in NAFLD-associated HCC in HepPten- mice and further demonstrated the important role of TLR4 in promoting HCC development. This study also identified IL-6 and IL-10 as markers of TLR4 activation in HCC and subjects with NAFLD and obesity as the target population who would benefit from TLR4 inhibition treatment for HCC chemoprevention.",
keywords = "Chemoprevention, Hepatocellular carcinoma, Mouse model, NAFLD, Toll-like receptor 4",
author = "Jennifer Nguyen and Jingjing Jiao and Kristin Smoot and Watt, {Gordon P.} and Chen Zhao and Xingzhi Song and Heather Stevenson-Lerner and McCormick, {Joseph B.} and Fisher-Hoch, {Susan P.} and Jianhua Zhang and {Andrew Futreal}, P. and Laura Beretta",
year = "2018",
month = "6",
day = "29",
doi = "10.18632/oncotarget.25685",
language = "English (US)",
volume = "9",
pages = "29495--29507",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "50",

}

TY - JOUR

T1 - Toll-like receptor 4

T2 - A target for chemoprevention of hepatocellular carcinoma in obesity and steatohepatitis

AU - Nguyen, Jennifer

AU - Jiao, Jingjing

AU - Smoot, Kristin

AU - Watt, Gordon P.

AU - Zhao, Chen

AU - Song, Xingzhi

AU - Stevenson-Lerner, Heather

AU - McCormick, Joseph B.

AU - Fisher-Hoch, Susan P.

AU - Zhang, Jianhua

AU - Andrew Futreal, P.

AU - Beretta, Laura

PY - 2018/6/29

Y1 - 2018/6/29

N2 - The incidence of hepatocellular carcinoma (HCC) associated with non-alcoholic fatty liver disease (NAFLD) is rapidly increasing. We aimed to elucidate the genetic basis of NAFLD-associated HCC and identify candidate targets for chemoprevention. Twenty HCC tumors, distant liver and matched tails from mice with hepatocytedeletion of Pten (HepPten-) were subjected to whole-exome sequencing. A total of 162 genes with somatic non-synonymous single nucleotide variants or exonic small insertions and deletions in tumors were identified. Ingenuity Pathway Analysis of these 162 genes, further identified Toll-like receptor (TLR) 4, a key mediator of proinflammatory responses, and resatorvid, a TLR4 inhibitor, as the main causal networks of this dataset. Resatorvid treatment strongly prevented HCC development in these mice (p < 0.001). Remarkably, HCC patients with high tumoral TLR4 mRNA expression were more likely to be diagnosed with NAFLD and obese. TLR4 mRNA expression positively correlated with IL-6 and IL-10 mRNA expression in HCC tumors and the correlation was stronger in obese HCC patients. We have identified tumor mutation signatures and associated causal networks in NAFLD-associated HCC in HepPten- mice and further demonstrated the important role of TLR4 in promoting HCC development. This study also identified IL-6 and IL-10 as markers of TLR4 activation in HCC and subjects with NAFLD and obesity as the target population who would benefit from TLR4 inhibition treatment for HCC chemoprevention.

AB - The incidence of hepatocellular carcinoma (HCC) associated with non-alcoholic fatty liver disease (NAFLD) is rapidly increasing. We aimed to elucidate the genetic basis of NAFLD-associated HCC and identify candidate targets for chemoprevention. Twenty HCC tumors, distant liver and matched tails from mice with hepatocytedeletion of Pten (HepPten-) were subjected to whole-exome sequencing. A total of 162 genes with somatic non-synonymous single nucleotide variants or exonic small insertions and deletions in tumors were identified. Ingenuity Pathway Analysis of these 162 genes, further identified Toll-like receptor (TLR) 4, a key mediator of proinflammatory responses, and resatorvid, a TLR4 inhibitor, as the main causal networks of this dataset. Resatorvid treatment strongly prevented HCC development in these mice (p < 0.001). Remarkably, HCC patients with high tumoral TLR4 mRNA expression were more likely to be diagnosed with NAFLD and obese. TLR4 mRNA expression positively correlated with IL-6 and IL-10 mRNA expression in HCC tumors and the correlation was stronger in obese HCC patients. We have identified tumor mutation signatures and associated causal networks in NAFLD-associated HCC in HepPten- mice and further demonstrated the important role of TLR4 in promoting HCC development. This study also identified IL-6 and IL-10 as markers of TLR4 activation in HCC and subjects with NAFLD and obesity as the target population who would benefit from TLR4 inhibition treatment for HCC chemoprevention.

KW - Chemoprevention

KW - Hepatocellular carcinoma

KW - Mouse model

KW - NAFLD

KW - Toll-like receptor 4

UR - http://www.scopus.com/inward/record.url?scp=85049225215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049225215&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.25685

DO - 10.18632/oncotarget.25685

M3 - Article

AN - SCOPUS:85049225215

VL - 9

SP - 29495

EP - 29507

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 50

ER -